In 2023, Germany led European production of opacifying preparations with €1.0553 billion, followed by France (€0.74768 billion) and Italy (€0.39757 billion). The Netherlands showed the highest year-on-year growth in 2023 with 7.39%, while Denmark and Spain also saw significant increases of 5.21% and 5.19%, respectively. France experienced the lowest growth at 1.67%, indicating potential stabilization or saturation in that market.
Future trends to watch include:
- Germany's continued dominance driven by advanced healthcare infrastructure.
- The Netherlands could maintain its high growth trajectory through innovation and market expansion.
- Italy might experience steady growth as healthcare investments rise.
- Spain and Denmark could continue to benefit from increased demand and healthcare improvements.
Top countries in Sold Production of Opacifying Preparations for X-Ray Examinations, Diagnostic Reagents Designed to Be Administered to the Patient by Country
| # | 7 Countries | Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 1,055,300,000 | 2023 | +0.53% | +2.07% | View data |
| 2 | 2 France | 747,680,000 | 2023 | -0.46% | +1.67% | View data |
| 3 | 3 Italy | 397,570,000 | 2023 | +0.37% | +2.26% | View data |
| 4 | 4 Netherlands | 320,290,000 | 2023 | +5.05% | +7.39% | View data |
| 5 | 5 Spain | 114,590,000 | 2023 | +7.58% | +5.19% | View data |
| 6 | 6 Denmark | 21,553,000 | 2023 | +1.05% | +5.21% | View data |
| 7 | 7 Czechia | 3,913,200 | 2023 |
